Keywords: prostrakan, files, response, fda, action, letter, fortigel

ProStrakan files response to FDA

Article | 07 May 2009

Scottish drugmaker ProStrakan has filed its complete response to the US Food and Drug Administration's action letter on Fortigel (2% testosterone ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Striant

Testosterone

Testoderm

Testim

Testosterone Gel

Go to drug listing